A specific strain of gut bacteria, Ruminococcus Gnavus, can enhance the efficacy of cancer immunotherapy. Tumors in mice shrank once researchers introduced Ruminococcus Gnavus to mice.
A specific strain of gut bacteria, Ruminococcus Gnavus, can enhance the efficacy of cancer immunotherapy. Tumors in mice shrank once researchers introduced Ruminococcus Gnavus to mice.